Skip to main content
Hyper Corporation Inc. logo

Hyper Corporation Inc. — Investor Relations & Filings

Ticker · 065650 ISIN · KR7065650004 KO Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 391 across all filing types
Latest filing 2024-07-31 M&A Activity
Country KR South Korea
Listing KO 065650

About Hyper Corporation Inc.

https://hyper-corp.com/

Hyper Corporation Inc. is a company transitioning from a clinical-stage biopharmaceutical firm to a new-tech-based platform provider. Its core Bio & Healthcare division develops treatments and diagnostic technologies for neurodegenerative diseases like Alzheimer's, aiming to build a comprehensive digital senior healthcare platform. The company is expanding by integrating AI and blockchain technologies into new sectors. Its IP & Content division focuses on securing intellectual property and innovating content distribution, while its New Tech division develops platforms to connect online and offline services. This strategy fuses its biotechnology expertise with advanced IT to create new business models and services.

Recent filings

Filing Released Lang Actions
[기재정정]타법인주식및출자증권취득결정(종속회사의주요경영사항)
M&A Activity Classification · 100% confidence The document is a regulatory filing from a Korean company (Hyper Corporation) regarding the acquisition of shares in another company (X-Cure Co., Ltd.) by its subsidiary. It follows the standard format for 'Major Management Matters' (주요경영사항) filings in the Korean market, specifically detailing the acquisition of equity securities. Since this is a specific corporate action announcement regarding investment and capital allocation, it falls under the 'Regulatory Filings' category as it does not fit into specific categories like M&A (which usually implies full takeover/merger) or Share Issue (which is about the company's own capital).
2024-07-31 Korean
[기재정정]타법인주식및출자증권취득결정
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from the Korean financial market (DART system style) titled '타법인주식및출자증권취득결정' (Decision to acquire shares and securities of another corporation). It is a formal disclosure regarding a capital investment/acquisition of shares in an investment fund (AI Mindbot Equity). Since this is a specific regulatory disclosure regarding a corporate transaction (acquisition of shares) and does not fit into the other specific categories like M&A (which usually implies a takeover or merger) or Capital/Financing (which usually implies raising capital), it is classified as a general Regulatory Filing (RNS).
2024-07-31 Korean
타법인주식및출자증권취득결정(종속회사의주요경영사항)
M&A Activity Classification · 100% confidence The document is a regulatory filing from a Korean company (Hyper Corporation) detailing the acquisition of shares in another company (X-Cure) by its subsidiary. This type of disclosure regarding the acquisition of shares or equity securities is classified as a corporate action related to capital structure or investment activity. In the context of the provided categories, this fits best under 'Regulatory Filings' (RNS) as it is a standard corporate disclosure announcement regarding a material business event that does not fall into specific categories like M&A (which usually implies a merger or takeover of the whole entity) or Share Issue (which refers to the company's own capital changes).
2024-07-26 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act (Article 147). It details changes in share ownership, including major shareholding notifications and changes in control. This falls under the 'Major Shareholding Notification' category.
2024-07-26 Korean
타법인주식및출자증권취득결정
M&A Activity Classification · 100% confidence The document is a regulatory filing from a Korean company (Hyper Corporation) announcing the acquisition of shares in another entity (AI Mindbot Equity). This type of disclosure, detailing the acquisition of equity, the purpose of the investment, and the financial impact on the company, is classified as a regulatory filing regarding corporate activity. Since it does not fit into specific categories like M&A (which usually implies a merger or takeover of a business entity rather than a portfolio investment/capital allocation) or other specialized categories, it falls under the general regulatory filing category.
2024-07-25 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Report' (주요사항보고서) regarding the 'Decision to Issue Convertible Bonds' (전환사채권 발행결정) and is explicitly labeled as a 'Correction Report' (정정신고). It details the terms of the convertible bond issuance, including conversion prices, interest rates, and redemption options. This falls under the category of capital and financing updates, specifically for convertible debt instruments.
2024-07-25 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.